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Background: The relationship between Body Mass Index (BMI) and Risk of Venous 
thromboembolism (VTE)  and Pulmonary Embolism (PE) is a controversial issue. This dose-
response meta-analysis was performed to investigate the association between BMI and risk of 
VTE and PE incidence based on cohort studies.  
Method: A comprehensive systematic search was conducted up to August 2019 in 
MEDLINE/PubMed, SCOPUS, and Cochrane. DerSimonian and Laird random-effects models 
were run to estimate combined hazard ratios (HRs) with 95% confidence intervals (CIs). Dose-
response analysis was also carried out based on BMI values.  
Results: Eleven articles with 16 arms and 3,910,747 participants were eligible for inclusion in this 
systematic review and meta-analysis. Pooled results showed a positive association between BMI 
and risk of VTE in the obese participants compared to participants classified in the normal BMI 
category (HR: 1.62, 95% CI: 1.29 -2.04, I2=95%). Furthermore, results showed a significant 
association between lower BMI (underweight versus normal BMI category) and reduced risk of 
PE (HR: 0.80, 95% CI: 0.70 -0.92, I2=9%) and higher risk of PE in obese versus normal BMI 
participants (HR: 2.24, 95% CI: 1.93 -2.60, I2=0%). There was a significant linear relationship 
between BMI and risk of VTE (p<0.001) and PE (p<0.001).  
Conclusions: This systematic review and dose-response meta-analysis with 3,910,747 participants 
highlights obesity as a significant risk factor related to the incidence of VTE and PE. 
Keywords: Body Mass Index; Venous thromboembolism; Pulmonary Embolism. 
 
1. INTRODUCTION 
Venous thromboembolism (VTE) is a composite disease, comprising of both deep venous 
thrombosis (DVT) and pulmonary embolism (PE). PE is often life threatening, but both diseases 
represent a major public health challenge in the 21st century [1]. Current estimates of incidence in 
Europe is between 104-183 per 100,000 person-years, making it comparable to cerebrovascular 
incidents [2]. With a growing ageing population, incidence rates may be as high as 700 per 100,000 
among individuals aged >70 years [3].  
 In tandem with this rise in VTE incidence, the global prevalence of obesity has increased, 
reaching pandemic rates, possibly driven by environmental factors associated with 
Westernization [4]. While close attention has been given to the chronic metabolic sequelae of 
obesity, the role of phenotype, which puts individuals at elevated risk of other life-altering 
diseases such as VTE, is poorly understood [5-7]. A number of existing biologically plausible 
theories, which align with Virchow’s triad, include: endothelial dysfunction as a result of the low-
grade inflammation associated with obesity [8]; excess truncal adiposity and intra-abdominal 
pressure resulting in poor venous return and hemostasis [9]; and low-grade inflammation-
induced hypercoagulable/hypofibrinolytic state (i.e., elevated circulating plasma fibrinogen and 
plasminogen activator inhibitor-1) [10]. A trend analysis by Wei and colleagues showed that DVT 
rates among VTE patients plateaued between 1985 and 2009, but overall VTE rates continue to 
climb as a result of increased PE incidence [11]. Despite medical advancement in addressing many 
of the known risk factors of VTE, such as rapid post-operative mobilization, anti-embolism 
stockings, and prophylactic heparin, the incidence is still rising. This perhaps indicates scope for 
evaluating other risk factors, known or unknown. 
 This systematic review and meta-analysis therefore aimed to evaluate and synthesize 
clinical evidence from cohort studies which examined the relationship between body mass index 
(BMI) and risk of VTE and PE. In addition, we explore the relationship between BMI and the two 
disease states in a dose-response manner. 
 
2. MATERIALS AND METHODS  
The MOOSE (Meta-analysis of Observational Studies in Epidemiology) guidelines were applied 
to the present meta-analysis [12]. A literature search for prospective cohort studies in 
PubMed/MEDLINE, Scopus, and Cochrane Library databases was performed by two 
independent reviewers and without any time or language restrictions up to August 2019. This 
comprehensive search was designed using Mesh and relative keywords of Body Mass Index and 
thromboembolism (Supplementary Table 1). An email alert service was activated to avoid the 
omission of any new articles published after the search period and a reference list of relevant 
original and review papers was scrutinized to identify additional studies.  
2.1. Inclusion criteria 
1) Cohort design studies; 2) reporting hazard ratio (HR) or risk ratio and the corresponding 
95% confidence interval (CI) of thromboembolism (venous thromboembolism and/or 
pulmonary embolism) based on BMI categories. VTE in this study is referring to both DVT 
and PE. 
2.2. Exclusion criteria 
1) Studies performed on cohorts with concomitant gastrointestinal disorders; 2) reviews, 
editorials, non-human, in vitro, case reports, ecological, and letters studies; 3) studies 
performed in children. 
2.3. Data extraction and quality assessment 
Data extraction was performed using designed and piloted extraction forms by two independent 
authors and discrepancies were resolved through discussion with the senior author. Extraction 
forms contained the following variables: first author, publication year, study country of origin, 
number of participants, mean age, gender, name of cohort, length of study follow-up, type of 
thromboembolism, BMI category, and hazard ratios with corresponding 95% CIs. The Newcastle-
Ottawa Quality Assessment Scale (NOS) was used to assess the methodological quality of the 
studies.   
2.4. Statistical analysis 
All statistical analyses were performed using STATA 14.0 statistical software (Stata Corporation, 
College Station, Texas, USA). DerSimonian and Laird random-effects model was run to combine 
risk estimates in included studies [13]. Cohort studies that reported each gender separately were 
considered as two arms. When authors did not report mean data for BMI categories, the median 
or mean in each category was used as the reference category. Underweight and obese categories 
were compared to normal category of BMI as a reference category. According WHO standards, 
we considered BMI below 18.5 as underweight, 18.5 to 25 as normal, 25 to 30 as overweight, and 
above 30 as obese. When two or more category of BMI in each original papers fell into the same 
category of our cut-points, risk estimates of those categories were combined, furthermore, if one 
category of BMI of included study covered two or more categories of our cutpoints, risk estimates 
of that category were assigned with its median. The heterogeneity among included studies was 
estimated by the Cochran Q test (p heterogeneity) and I2 statistic. Random-effects meta-regression 
based on age of participants was conducted to identify the source of heterogeneity. Curve-linear 
association was examined by modeling concentration level using restricted cubic splines [14]. 
Linear results are based on exponential with y = mx +c formula and used to check the general 
trend between BMI and outcome, but nonlinear analysis is based on the coefficient with ax2 + 
by2 = c formula, which was used for comparing underweight or obesity versus normal weight. 
Funnel plot, Begg's rank correlation test, and Egger's regression asymmetry test were conducted 
to evaluate publication bias among included studies.  
 
3. RESULTS 
3.1. Literature search 
The flow chart of included studies is presented in Figure 1. The initial database search yielded 
5544 records, of these 1418 articles were subsequently removed as duplicates. At title and/or 
abstract screening, 4059 irrelevant articles were excluded, and 67 articles were included in full 
text screening. At full text screening, 56 articles were removed using the inclusion and exclusion 
criteria. Eleven articles with 16 arms and 3,910,747 participants were eligible for inclusion in this 
systematic review and meta-analysis [15-25]. 
3.2. Study characteristics and quality assessment 
Baseline characteristics of included studies are presented in Table 1. Studies were published 
between 2009 and 2018. Five studies were conducted in USA [15, 17, 20, 22, 24], two in Denmark 
[18, 25], one in Israel [16], one in Norway [21], one in Italy [23], and one in New Zealand[19] . The 
mean age of participants was 44 years, with a range from 17 to 60 years. The mean length of 
follow-up was 13 years, with a range from 4 to 28 years. Four studies [16, 19, 20, 24] evaluated 
pulmonary embolism in four arms and venous thromboembolism in 13 arms [15, 17-23, 25]. All 
studies had good quality and seven of them achieved the maximum score on the Newcastle-
Ottawa Quality Assessment Scale (9). 
3.3. Main results of the meta-analysis 
Three studies with five arms provided a total of 1,395,384 participants reporting risk of VTE in 
underweight participants versus normal weight as outcome measures [15, 19, 25]. The pooled HR 
(95% CI) in the underweight versus the normal category of BMI was (HR: 1.01, 95% CI: 0.91-1.23, 
I2=89%) for risk of VTE (Fig. 2).  Meta-regression identified that participant's age was the source 
of heterogeneity among included studies (p=0.01). 
Nine studies with 12 arms provided a total of 1,529,382 participants for evaluating the risk 
of VTE in obese participants versus normal weight [15, 17-23, 25]. Combined results of included 
studies demonstrated a positive association between BMI and risk of VTE in the obese 
participants versus participants classified in the normal BMI category (HR: 1.62, 95% CI: 1.29 -
2.04, I2=95%) (Fig. 3). Meta-regression based on participants age was identified as the source of 
heterogeneity in the study results, with higher BMI among older participants showing a stronger 
relation with risk of VTE (p=0.01) (Supplementary Fig. 1). 
Four studies with 3,572,774 participants provided data for evaluating the relationship 
between BMI and risk of PE [16, 19, 20, 24]. Combined results using a random effects model 
showed a significant association between lower BMI (underweight versus normal BMI category) 
and reduced risk of PE (HR: 0.80, 95% CI: 0.70 -0.92, I2=9%) (Fig. 4). Furthermore, results showed 
higher risk of PE in obese versus normal BMI participants (HR: 2.24, 95% CI: 1.93 -2.60, I2=0%) 
(Fig. 5). 
3.4. Dose-response analysis 
The dose-response relationships between BMI and risk of VTE are presented in Figure 6. 
Although there was a significant linear relationship between BMI and risk of VTE (p<0.001), an 
insignificant, non-linear relationship was apparent (p=0.69). Figure 7 shows a significant 
relationship between BMI and risk of PE (p<0.001) and an insignificant, non-linear relationship 
(p=0.32). 
3.5. Publication bias 
Funnel plots did not show any asymmetry among included studies (Supplementary Figure 3). 
No publication bias was found among the studies (the Begg’s p=0.99 and 0.27 and Egger tests 
p=0.80 and 0.35 for risk of VTE in underweight and obese versus normal weight, respectively and 
the Begg’s p=0.99 and 0.05 and Egger tests p=0.48 and 0.17 for risk of pulmonary embolism in 
underweight and obese versus normal weight, respectively). 
4. Discussion  
This systematic review critically appraised and summarized the evidence base using large scale 
cohort studies that evaluated the relationship between body mass index and the risk of VTE and 
PEThe findings of this systematic review suggest that a higher body mass index increases the risk 
of venous and pulmonary embolism. We found no evidence of a relationship between being 
underweight and developing VTE (HR: 1.06 95% CI: 0.91-1.23). However, a protective 
relationship was found between being underweight and the risk of PE(HR: 0.80 95% CI: 0.70-
0.92); but this might be due to the complexity involved with diagnosing PE[26]. The hazard ratio 
was 1.5 times higher (HR: 1.62 95% CI: 1.29-2.04) for VTE and two-fold (HR: 2.24 95% CI: 1.93-
2.60) for PE among obese individuals compared with normal BMI. These results are supported 
by evidence from a previous review that showed a two-fold increase in risk of VTE[5]. A review 
by Yi and colleagues (2016) evaluated risk factors for VTE and atherosclerosis. The authors 
reported higher prevalence of VTE among participants with BMI ≥30 kg/m2 than their counterparts 
with lower BMI. Although the authors did not adjust for sex as a confounding variable and 
included data from case-controlled studies prone to bias when establishing baseline exposure and 
outcome [27], the results showed consistent and large estimates similar to evidence generated by 
this review.  
4.1. Clinical significance  
obesity may be an independent risk factor for VTE and PE but the mechanism of action for this 
association is unclear [28]. These vascular disorders are most likely triggered by biological stimuli 
of pathophysiological responses (characteristic of inflammation, hypercoagulability, and 
endothelial injury) within blood vessels or adipose tissue. Multiple interacting factors are 
associated with the risk of VTE and PE; therefore, reducing their impact may require multiple 
intervention approaches [28]. For example, anticoagulation treatment alone may not alter immune 
response to inflammation in VTE and PE [29]. Moreover, findings from studies included in this 
review may be more applicable to clinical settings within  developed countries due to differences 
in environmental factors, prophylaxis and medical interventions such as biomarkers risk 
stratification [30]. It might be helpful for future studies to explore the relationship between 
inflammatory mediators such as C-reactive protein (CRP), tumor necrosis factor-alpha, IL-6, and 
IL-8, and risk of VTE or PE. This would help to inform clinical decision making, and the design 
and delivery of preventative treatment strategies [29]. 
Adequate management of BMI as a risk factor might reverse or reduce risk of VTE and PE by 
reducing circulating hypercoagulation factors within the blood stream [27]. This mechanism of 
action is probably partly mediated by the protective effect of improving lipid profiles in arterial 
thrombosis and the release of antioxidants that reduce inflammation. Our findings suggest that 
weight loss in addition to other preventive strategies within primary and secondary care settings 
are integral to reducing the incidence of VTE and PE. However, the precise nature through which 
the dose-dependent relationship could guide treatment dosage remains unclear. For example, 
uncovering the mechanism of action could determine guidelines for treatment regimens such as 
weight-to-prophylaxis ratio or suitable target weight for improving surgical outcomes [31].   
 
4.2. Limitations  
A comprehensive search strategy was developed and used to identify relevant articles. In 
addition, we did not identify any evidence of publication bias, but papers published in the grey 
literature may have been missed. Even assessments of publication bias, though helpful, can still 
be misleading with heterogeneous samples and/or small study numbers. Furthermore, although 
we reported a dose-response relationship between higher BMI and risk of VTE and PE, this does 
not imply causality. As randomized controlled trials (RCTs) which elucidate causality may be 
difficult to execute, it might be useful to perform analysis of routine data to illustrate current 
obesity trends, absolute risks and numbers needed-to-treat. Secondary data analysis of RCTs that 
account for known and unknown confounders may prove helpful to evaluate the effect of 
reduced body weight and physiological drivers of coagulation within blood vessels to enhance 
therapy.  
Furthermore, using BMI as a self-reported, surrogate outcome measure for classifying risk 
profiles is prone to measurement errors due to misclassification bias. Anthropometric measures 
such as central obesity, and waist and hip circumference have been reported to be more sensitive 
indicators of risks than BMI. Although we adjust for the effect of age, we did not explore the effect 
of unknown or residual confounding variables such as genetics, anti-coagulative therapy, levels 
of physical activity, duration of follow-up, existing comorbidities, lifestyle or demographic 
factors and their interactions with each other.  
For    VTE, the associated I-squared statistic showed significant heterogeneity, whilst our meta-
regression indicated that age was the source of heterogeniety. Indeed, specific to this finding, it 
was evident that among older particpants, the relationship between high BMI and risk of VTE 
was stronger.  Clearly, this highlights the agemust be taken into consideration when interpreting 
the results. Whilst extrapolating this finding into clinical practice would dictate that, in aging 
patients, a high BMI should be far more acutely considered and managed. Moreover, in the 
presence of such extreme I-squared values, Higgins et al suggest that a wider investigation of 
variability across studies, with respect to the source of heterogeneity, in our case, age, be 
undertaken to better understand and delineate clinical implications. Whilst we show that age is 
a significant source of heterogeneity, BMI and VTE was the focus of our investigation, and 
therefore, it was out of the scope of the present work to further address this heterogeneity. 
However, we therefore suggest that further work, with specific age groups be conducted to allow 
better understanding of how and why certain age groups may be more or less at risk of VTE. 
. 
 
5. Conclusions  
This systematic review provides up-to-date evidence on the relationship between body mass 
index and risk of venous and pulmonary embolism and demonstrated a positive and strong 
relationship between BMI and venous or pulmonary embolism. Studies that investigate other 
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